热门资讯> 正文

enVVeno Medical报告第二季度业绩

2025-08-01 20:45

enVVeno Medical press release (NASDAQ:NVNO): Q2 The Company reported net losses of $6.7 million and $5.0 million for the three months ended June 30, 2025 and 2024, respectively, representing an increase in net loss of $1.7 million, or 35%.
Cash burn for the quarter was $3.8 million, consistent with the Company's projected cash burn rate of approximately $4-5 million per quarter.

More on enVVeno Medical

Seeking Alpha’s Quant Rating on enVVeno Medical
Historical earnings data for enVVeno Medical
Financial information for enVVeno Medical

推荐文章

风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。